are they stopping semaglutide Two Years After GLP-1s, Most Patients Sustain at Least Some Weight Loss While nearly 18% of U.S.

Long-term data shows that patients who remain on semaglutide maintain their weight loss better than those who discontinue, suggesting ongoing GLP-1 receptor activation is necessary for sustained results

The role of adherence and persistence is beyond the scope of this study but a promising area of further research is to explore which patients may benefit from this medication class, and how to ensure that the benefits of GLP-1 medications are fully realized in a real-world setting by addressing poor adherence

MOTS-c as a solo compound remains valuable for insulin sensitivity, mitochondrial health, and exercise-performance-adjacent research

The key factor in efficacy is compliance, because the oral version requires strict adherence to the empty stomach rule